
Desmoglein I Antibody (Vesiculobullous Disorders)









The Desmoglein I Antibody (Vesiculobullous Disorders) test is a blood test that detects antibodies against desmoglein 1, a protein responsible for maintaining adhesion between skin cells. This test helps in diagnosing autoimmune blistering skin disorders, especially pemphigus foliaceus, where the immune system mistakenly attacks the skin’s upper layers.












Understanding Desmoglein I Antibody (Vesiculobullous Disorders)
Desmoglein 1 is a cell adhesion molecule found in the upper layers of the epidermis. It belongs to the cadherin family and plays a vital role in binding skin cells together and maintaining the integrity of the skin barrier. In certain autoimmune blistering disorders, the body produces autoantibodies against desmoglein 1, disrupting these cell connections and leading to superficial blisters or erosions. The Desmoglein I Antibody (Vesiculobullous Disorders) test detects the presence of these autoantibodies in the blood. It is also helpful in diagnosing autoimmune blistering disorders, which cause superficial fragile blisters, crusted erosions, and scaling lesions mainly affecting the skin, typically without mucosal involvement, depending on the specific type of pemphigus.
This test is used to help diagnose pemphigus foliaceus, which is characterized by skin blistering without mucosal involvement. It can also help differentiate between types of pemphigus (e.g., foliaceus vs vulgaris) and disorders like bullous pemphigoid require different antibody tests (e.g., BP180, BP230).
Doctors may recommend the Desmoglein I Antibody (Vesiculobullous Disorders) test if you experience symptoms such as painful blisters, erosions, or sores on the skin or mucous membranes. It is primarily used to support diagnosis in patients with clinical suspicion of autoimmune blistering disorders, such as pemphigus, rather than as a general screening test, as autoantibody tests like Dsg1 ELISA are not intended for routine screening. The test also helps confirm the diagnosis of specific vesiculobullous disorders. In patients already diagnosed with autoimmune blistering conditions, it is useful for monitoring disease activity and assessing response to treatment. Additionally, it may be considered in individuals with a family history of these disorders who may be at increased risk.
No special preparation is required for this test. Inform your doctor about all the medications and supplements that you are currently taking, as these may affect the test results.
Test result ranges are approximate and may differ slightly between labs depending on the methodology and laboratory guidelines. Do not self-medicate, and always consult a doctor to understand the test results correctly.
Please note: This is an outsourced test. The sample for this test is collected by TATA 1MG and processed at a NABL accredited partnered lab.
What does Desmoglein I Antibody (Vesiculobullous Disorders) measure?
The Desmoglein I Antibody (Vesiculobullous Disorders) test measures the presence of autoantibodies directed against desmoglein 1 in the blood. Desmoglein 1 is a protein that plays a key role in keeping skin cells bound together in the upper layers of the epidermis. When the immune system mistakenly produces antibodies against this protein, the cell-to-cell adhesion is disrupted, leading to fragile skin and the formation of superficial blisters or erosions. A positive test result is strongly associated with pemphigus foliaceus, an autoimmune blistering disorder. In addition to diagnosis, the level of antibodies detected can provide insight into disease severity, as higher concentrations often reflect more active disease and can help in monitoring treatment response.





FAQs related to Desmoglein I Antibody (Vesiculobullous Disorders)
- Delavarian Z, Layegh P, Pakfetrat A, Zarghi N, Khorashadizadeh M, Ghazi A. Evaluation of desmoglein 1 and 3 autoantibodies in pemphigus vulgaris: correlation with disease severity. J Clin Exp Dent. 2020 May 1;12(5):e440-e445. [Accessed 26 Sep. 2025]. Available From:
- Zheng C, Shi P, Sun Y, Liu Y, Wang Z, Li W, Cao S, Liu H, Zhang F. Bullous pemphigoid with anti-desmoglein antibodies: An incident of coincidence or not? Chin Med J (Engl). 2025 Mar 5;138(5):619-621. [Accessed 26 Sep. 2025]. Available From:
- Lepe K, Yarrarapu SNS, Zito PM. Pemphigus Foliaceus. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from:
- James KA, Culton DA, Diaz LA. Diagnosis and clinical features of pemphigus foliaceus. Dermatol Clin. 2011 Jul;29(3):405-12, viii. [Accessed 26 Sep. 2025]. Available From:
Other tests
- PT INR (Prothrombin Time with INR)
- HIV 1 and 2 Antibody, Rapid Screening Test
- Viral Marker Screening (HIV, HBsAg, Anti-HCV)
- Total IgE
- Rheumatoid Factor - Quantitative
- STD Panel (Sexually Transmitted Diseases Panel)
- STD Panel (Sexually Transmitted Diseases Panel),
- HIV Combo (Antigen And Antibody) Test
- Anti-CCP Antibody
- Lipid Profile, Non Fasting,
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)













